CLAIM #69799 · EMR (EMR) · 2026Q3 earnings call · Nov 2, 2026 · due Dec 31, 2027
“At this point, I continue to be relatively robust on semiconductors through 2027.”
Lal Karsanbhai · CEO
PENDING
graded after results covering Dec 31, 2027 are reported
In context
“Lal Karsanbhai (President and Chief Executive Officer): I'll follow up on the semiconductor question. We're not guiding into 2027 today, but you can read into the tremendous order momentum we have in the semiconductor business within Test & Measurement. There is differentiation in growth by application. The validation and production side, where we largely play, has a different dynamic on growth and the cycle as well. At this point, I continue to be relatively robust on semiconductors through 2027.”
Verify independently
SEC filings for EMR ↗ · Claim quote is verbatim from the 2026Q3 earnings call.